scholarly journals Gastric Bypass Prior to Simultaneous Pancreas-Kidney Transplantation for Optimization of Diabetic Management

2020 ◽  
pp. 1-3
Author(s):  
Jay A. Graham ◽  
Jay A. Graham ◽  
Juan P. Rocca ◽  
Julia Torabi ◽  
Nidal Muhdi ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Gastric Bypass ◽  
Kidney Transplantation ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Increased Risk ◽  
Operative Complications ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation

Morbid obesity is a relative contraindication for abdominal organ transplantation. Obese patients present technical challenges intra-operatively and are at increased risk of post-operative complications. Bariatric surgery has been shown to be more effective than conventional weight loss strategies in morbidly obese patients, however, current literature is limited to the kidney transplant population. Here were present a case report of a patient with morbid obesity who underwent a laparoscopic Roux-en-Y gastric bypass prior to simultaneous pancreas kidney transplantation.

scholarly journals Robotic Roux-en-Y gastric bypass: operative results in 100 patients

2014 ◽  
Vol 27 (suppl 1) ◽  
pp. 9-12 ◽  
Author(s):  
Carlos Eduardo DOMENE ◽  
Paula VOLPE ◽  
Frederico A. HEITOR
Keyword(s):  
Morbid Obesity ◽  
Gastric Bypass ◽  
Gastric Pouch ◽  
The Body ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Super Obese ◽  
Robotic Gastric Bypass ◽  
Operative Complications ◽  
Biliopancreatic Limb

BACKGROUND: Laparoscopic gastric bypass is gold-standard for morbid obesity treatment. AIM: To describe the results of robotic gastric bypass for morbid obesity patients. METHOD: Were operated on 100 morbidly obese patients through totally robotic gastric bypass between 2013 and 2014. They were 83% female. The age ranged from 20 to 65 years old (medium 48,5 years); the body mass index varied between 38-67 (medium 42,3 kg/cm2). The procedure was designed with 3 cm long gastric pouch, 1 m biliopancreatic limb, 1,2 m alimentary limb, manual or stapled anastomosis. There were four super-super-obese patients and four revisional surgeries. RESULTS: Docking time varied from 1 to 20 min (medium 4 min). Console time varied from 40-185 min (medium 105 min). There were no intra operative complications or mortality. There were two lower limb deep venous thrombosis. There was no readmission in the first 30 days. CONCLUSION: Totally robotic gastric bypass is safe and reproduceable, with excellent results even during the initial experience with regular surgeries, revisional surgeries or in super-obese patients. Adequate training may shortens or obviates the learning curve.

scholarly journals Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas–Kidney Transplantation (SPKT)—A Landmark Analysis

2021 ◽  
Vol 10 (15) ◽  
pp. 3237
Author(s):  
Lukas Johannes Lehner ◽  
Robert Öllinger ◽  
Brigitta Globke ◽  
Marcel G. Naik ◽  
Klemens Budde ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Graft Survival ◽  
Graft Loss ◽  
Type I ◽  
Kidney Graft ◽  
Landmark Analysis ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation ◽  
Pancreas Graft

(1) Background: Simultaneous pancreas–kidney transplantation (SPKT) is a standard therapeutic option for patients with diabetes mellitus type I and kidney failure. Early pancreas allograft failure is a complication potentially associated with worse outcomes. (2) Methods: We performed a landmark analysis to assess the impact of early pancreas graft loss within 3 months on mortality and kidney graft survival over 10 years. This retrospective single-center study included 114 adult patients who underwent an SPKT between 2005 and 2018. (3) Results: Pancreas graft survival rate was 85.1% at 3 months. The main causes of early pancreas graft loss were thrombosis (6.1%), necrosis (2.6%), and pancreatitis (2.6%). Early pancreas graft loss was not associated with reduced patient survival (p = 0.168) or major adverse cerebral or cardiovascular events over 10 years (p = 0.741) compared to patients with functioning pancreas, after 3 months. Moreover, kidney graft function (p = 0.494) and survival (p = 0.461) were not significantly influenced by early pancreas graft loss. (4) Conclusion: In this study, using the landmark analysis technique, early pancreas graft loss within 3 months did not significantly impact patient or kidney graft survival over 10 years.

scholarly journals Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation

2015 ◽  
Vol 29 (2) ◽  
pp. 173-183 ◽  
Author(s):  
Jorge Malheiro ◽  
La Salete Martins ◽  
Sandra Tafulo ◽  
Leonídio Dias ◽  
Isabel Fonseca ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Hla Antibodies ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation

scholarly journals Experience with Simultaneous Pancreas-kidney Transplantation

1988 ◽  
Vol 208 (4) ◽  
pp. 475-483 ◽  
Author(s):  
HANS W. SOLLINGER ◽  
ROBERT J. STRATTA ◽  
ANTHONY M. DʼALESSANDRO ◽  
MUNCI KALAYOGLU ◽  
JOHN D. PIRSCH ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Pancreas Kidney Transplantation ◽  
Simultaneous Pancreas Kidney ◽  
Simultaneous Pancreas Kidney Transplantation
Sign in / Sign up

Export Citation Format

Share Document